Shivalik Bimetal Controls Regulatory Approval

Board Meeting Date

Shivalik Bimetal Controls Board Meeting Date

Shivalik Bimetal Controls intimated a board meeting on 4 November 2026 to consider unaudited standalone and consolidated results for the quarter ended September 2026. This is advance notice only; no results are reported yet.

Other Announcement

Shivalik Bimetal Controls Other Announcement

The company submitted its quarterly shareholding pattern for the period ending September 30, 2026, confirming the recent reclassification of a promoter entity.

Other Announcement

Shivalik Bimetal Controls Other Announcement

Shareholders approved an amendment to the Articles of Association of Shivalik Bimetal Controls Limited to enable future capital raising initiatives. This is an enabling provision only.

Annual General Meeting

Shivalik Bimetal Controls Annual General Meeting

Shivalik Bimetal Controls held its 42nd Annual General Meeting on September 2, 2026. The meeting transacted ordinary and special business, including the re-appointment of a director.

Management Change

Shivalik Bimetal Controls Management Change

Shivalik Bimetal Controls Limited announced the sad demise of its Non-Executive Independent Director, Mr. Swarnjit Singh, on September 1, 2026.

Legal & Regulatory

Shivalik Bimetal Controls Legal & Regulatory

Shivalik Bimetal Controls reported a Code of Conduct violation under SEBI Insider Trading regulations by a former employee's relative. The audit committee is reviewing the incident.

Regulatory ApprovalShalby Ltd SHALBYAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Shalby Regulatory Approval

Shalby Hospital, Jabalpur received CMHO permission to resume normal operations, including patient admissions, on its previously affected floor. The hospital has now fully resumed healthcare services.

Regulatory ApprovalElantas Beck India Ltd ELANTASAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Elantas Beck India Regulatory Approval

Elantas Beck India's GPCB permanently revoked the closure direction on its Ankleshwar plant. The facility can keep operating, subject to compliance conditions.

Regulatory ApprovalKalyani Cast-Tech Ltd 544023Alfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Kalyani Cast-Tech Regulatory Approval

Kalyani Cast-Tech received RDSO Stage-I concept design approval for its new container-carrying wagon under PWDA. Stage-II detailed design approval is still required, subject to dynamics simulation conditions.

Regulatory ApprovalMukka Proteins Ltd MUKKAAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Mukka Proteins Regulatory Approval

Mukka Proteins received a US FDA facility registration certificate, valid October 1, 2026 to December 31, 2027. The company says the registration supports its engagement with US customers and markets.

Execution

October 1, 2026 to December 31, 2027

Regulatory ApprovalCanara Bank CANBKAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Canara Bank Regulatory Approval

Canara Bank received RBI permission to exercise the call option on its Basel III AT1 bonds (ISIN INE476A08134) of Rs.1,500 Crore. The bank is now in process of exercising the call as per the issue terms.

Value

₹1,500 Cr

Regulatory ApprovalAlembic Pharmaceuticals Ltd APLLTDAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Alembic Pharmaceuticals Regulatory Approval

Alembic Pharmaceuticals received USFDA final approval for Valganciclovir for Oral Solution, 50 mg/mL. This adds to its cumulative 247 USFDA ANDA approvals.